|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cervantes A, Roselló S, Roda D and
Rodriguez-Braun E: The treatment of advanced gastric cancer:
Current strategies and future perspectives. Ann Oncol. 19 Suppl
5:v103–v107. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
da Rocha AB, Lopes RM and Schwartsmann G:
Natural products in anticancer therapy. Curr Opin Pharmacol.
1:364–369. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang P, Yang HL, Yang YJ, Wang L and Lee
SC: Overcome cancer cell drug resistance using natural products.
Evid Based Complement Alternat Med. 2015:7671362015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jin MH, Yook J, Lee E, Lin CX, Quan Z, Son
KH, Bae KH, Kim HP, Kang SS and Chang HW: Anti-inflammatory
activity of Ailanthus altissima in ovalbumin-induced lung
inflammation. Biol Pharm Bull. 29:884–888. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bray DH, Boardman P, O'Neill MJ, Chan KL,
Phillipson JD, Warhurst DC and Suffness M: Plants as a source of
antimalarial drugs 5. Activities of Ailanthus altissima stem
constituents and of some related quassinoids. Phytother Res.
1:22–24. 1987. View Article : Google Scholar
|
|
8
|
Okunade AL, Bikoff RE, Casper SJ, Oksman
A, Goldberg DE and Lewis WH: Antiplasmodial activity of extracts
and quassinoids isolated from seedlings of Ailanthus altissima
(Simaroubaceae). Phytother Res. 17:675–677. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kundu P and Laskar S: A brief resume on
the genus Ailanthus: Chemical and pharmacological aspects.
Phytochem Rev. 9:379–412. 2010. View Article : Google Scholar
|
|
10
|
Fukamiya N, Lee KH, Muhammad I, Murakami
C, Okano M, Harvey I and Pelletier J: Structure-activity
relationships of quassinoids for eukaryotic protein synthesis.
Cancer Lett. 220:37–48. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rosati A, Quaranta E, Ammirante M, Turco
MC, Leone A and De Feo V: Quassinoids can induce mitochondrial
membrane depolarisation and caspase 3 activation in human cells.
Cell Death Differ. 11 Suppl 2:S216–S218. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Y, Wang WJ, Su C, Zhang DM, Xu LP, He
RR, Wang L, Zhang J, Zhang XQ and Ye WC: Cytotoxic quassinoids from
Ailanthus altissima. Bioorg Med Chem Lett. 23:654–657. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang XL, Yuan YL, Zhang DM, Li F and Ye
WC: Shinjulactone O, a new quassinoid from the root bark of
Ailanthus altissima. Nat Prod Res. 28:1432–1437. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhuo Z, Hu J, Yang X, Chen M, Lei X, Deng
L, Yao N, Peng Q, Chen Z, Ye W and Zhang D: Ailanthone inhibits
Huh7 cancer cell growth via cell cycle arrest and apoptosis in
vitro and in vivo. Sci Rep. 5:161852015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fuchs Y and Steller H: Programmed cell
death in animal development and disease. Cell. 147:742–758. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fulda S: Evasion of apoptosis as a
cellular stress response in cancer. Int J Cell Biol.
2010:3708352010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kaufmann SH and Earnshaw WC: Induction of
apoptosis by cancer chemotherapy. Exp Cell Res. 256:42–49. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vermeulen K, Van Bockstaele DR and
Berneman ZN: The cell cycle: A review of regulation, deregulation
and therapeutic targets in cancer. Cell Prolif. 36:131–149. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lundberg AS and Weinberg RA: Control of
the cell cycle and apoptosis. Eur J Cancer. 35:1886–1894. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang L, Liu X, Wu D, Zhang M, Ran G, Bi Y
and Huang H: Growth inhibition and induction of apoptosis in
SGC-7901 human gastric cancer cells by evodiamine. Mol Med Rep.
9:1147–1152. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang C, Chen Z, Zhou X, Xu W, Wang G,
Tang X, Luo L, Tu J, Zhu Y, Hu W, et al: Cantharidin induces G2/M
phase arrest and apoptosis in human gastric cancer SGC-7901 and
BGC-823 cells. Oncol Lett. 8:2721–2726. 2014.PubMed/NCBI
|
|
25
|
Fulda S: Tumor resistance to apoptosis.
Int J Cancer. 124:511–515. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kumar S: Caspase function in programmed
cell death. Cell Death Differ. 14:32–43. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu G and Shi Y: Apoptosis signaling
pathways and lymphocyte homeostasis. Cell Res. 17:759–771. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Adams JM and Cory S: The Bcl-2 apoptotic
switch in cancer development and therapy. Oncogene. 26:1324–1337.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Youle RJ and Strasser A: The BCL-2 protein
family: Opposing activities that mediate cell death. Nat Rev Mol
Cell Biol. 9:47–59. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bleicken S, Classen M, Padmavathi PV,
Ishikawa T, Zeth K, Steinhoff HJ and Bordignon E: Molecular details
of Bax activation, oligomerization, and membrane insertion. J Biol
Chem. 285:6636–6647. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dewson G, Kratina T, Sim HW, Puthalakath
H, Adams JM, Colman PM and Kluck RM: To trigger apoptosis, Bak
exposes its BH3 domain and homodimerizes via BH3:Groove
interactions. Mol Cell. 30:369–380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ghobrial IM, Witzig TE and Adjei AA:
Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin.
55:178–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
